Turkeli, M. Et Al. 2015. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.. Asian Pacific journal of cancer prevention : APJCP , vol.16 , 985-9.

Turkeli, M., Aldemir, M. N., Cayir, K., Simsek, M., Bilici, M., Tekin, S. B., ... Yildirim, N.(2015). Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.. Asian Pacific journal of cancer prevention : APJCP , vol.16, 985-9.

Turkeli, Mehmet Et Al. "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.," Asian Pacific journal of cancer prevention : APJCP , vol.16, 985-9, 2015

Turkeli, Mehmet Et Al. "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.985-9, 2015

Turkeli, M. Et Al. (2015) . "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.985-9.

@article{article, author={Mehmet Turkeli Et Al. }, title={Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.}, journal={Asian Pacific journal of cancer prevention : APJCP}, year=2015, pages={985-9} }